Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro
Authors:
Open Access
- 5 January 2001
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 84 (1) , 106-112
Abstract
The potent novel poly(ADP-ribose) polymerase (PARP) inhibitor, NU1025, enhances the cytotoxicity of DNA-methylating agents and ionizing radiation by inhibiting DNA repair. We report here an investigation of the role of PARP in the cellular responses to inhibitors of topoisomerase I and II using NU1025. The cytotoxicity of the topoisomerase I inhibitor, camptothecin, was increased 2.6-fold in L1210 cells by co-incubation with NU1025. Camptothecin-induced DNA strand breaks were also increased 2.5-fold by NU1025 and exposure to camptothecin-activated PARP. In contrast, NU1025 did not increase the DNA strand breakage or cytotoxicity caused by the topoisomerase II inhibitor etoposide. Exposure to etoposide did not activate PARP even at concentrations that caused significant levels of apoptosis. Taken together, these data suggest that potentiation of camptothecin cytotoxicity by NU1025 is a direct result of increased DNA strand breakage, and that activation of PARP by camptothecin-induced DNA damage contributes to its repair and consequently cell survival. However, in L1210 cells at least, it would appear that PARP is not involved in the cellular response to etoposide-mediated DNA damage. On the basis of these data, PARP inhibitors may be potentially useful in combination with topoisomerase I inhibitor anticancer chemotherapy.Keywords
This publication has 36 references indexed in Scilit:
- Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines ?with special reference to cisplatinJournal of Cancer Research and Clinical Oncology, 1996
- 3-Aminobenzamide: Effects on Cytochrome P450-Dependent Metabolism of Chemicals and on the Toxicity of Dichlobenil in the Olfactory MucosaToxicology and Applied Pharmacology, 1996
- Poly(ADP-ribose) polymerase: a molecular nick-sensorTrends in Biochemical Sciences, 1994
- Cellular Determinants of Sensitivity and Resistance to DNA Topoisomerase InhibitorsCancer Investigation, 1994
- The effect of the chemotherapeutic drug VP-16 on poly(ADP-ribosylation) in apoptotic HeLa cellsCarcinogenesis, 1993
- Cross-sensitivity of γ-ray-sensitive hamster mutants to cross-linking agentsMutation Research/DNA Repair, 1991
- Cell type dependent activation of poly(ADP-ribose) synthesis following treatment with etoposideLeukemia Research, 1990
- VP-16-induced nucleotide pool changes and poly(ADP-ribose) synthesis: The role of VP-16 in interphase deathExperimental Cell Research, 1989
- Disturbances in DNA precursor metabolism associated with exposure to an inhibitor of poly(ADP-ribose) synthetaseExperimental Cell Research, 1986
- Poly(ADP‐ribose) polymerase activity in nucleotide permeable cellsFEBS Letters, 1978